Report Detail

Medical Industry Global In Vivo and In Vitro ADME and PK Market Growth (Status and Outlook) 2021-2026

  • RnM4348844
  • |
  • 25 October, 2021
  • |
  • Global
  • |
  • 118 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Industry

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global In Vivo and In Vitro ADME and PK Market Size 2016-2026
    • 2.1.2 In Vivo and In Vitro ADME and PK Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 In Vivo and In Vitro ADME and PK Segment by Type
    • 2.2.1 Small Molecules
    • 2.2.2 Small Molecules
  • 2.3 In Vivo and In Vitro ADME and PK Market Size by Type
    • 2.3.1 Global In Vivo and In Vitro ADME and PK Market Size CAGR by Type
    • 2.3.2 Global In Vivo and In Vitro ADME and PK Market Size Market Share by Type (2016-2021)
  • 2.4 In Vivo and In Vitro ADME and PK Segment by End User
    • 2.4.1 Biopharmaceutical Companies
    • 2.4.2 Government and Academic Institutes
    • 2.4.3 Others
  • 2.5 In Vivo and In Vitro ADME and PK Market Size by End User
    • 2.5.1 Global In Vivo and In Vitro ADME and PK Market Size CAGR by End User
    • 2.5.2 Global In Vivo and In Vitro ADME and PK Market Size Market Share by End User (2016-2021)

3 In Vivo and In Vitro ADME and PK Market Size by Players

  • 3.1 In Vivo and In Vitro ADME and PK Market Size Market Share by Players
    • 3.1.1 Global In Vivo and In Vitro ADME and PK Revenue by Players (2019-2021E)
    • 3.1.2 Global In Vivo and In Vitro ADME and PK Revenue Market Share by Players (2019-2021E)
  • 3.2 Global In Vivo and In Vitro ADME and PK Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 In Vivo and In Vitro ADME and PK by Regions

  • 4.1 In Vivo and In Vitro ADME and PK Market Size by Regions (2016-2021)
  • 4.2 Americas In Vivo and In Vitro ADME and PK Market Size Growth (2016-2021)
  • 4.3 APAC In Vivo and In Vitro ADME and PK Market Size Growth (2016-2021)
  • 4.4 Europe In Vivo and In Vitro ADME and PK Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa In Vivo and In Vitro ADME and PK Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas In Vivo and In Vitro ADME and PK Market Size by Country (2016-2021)
  • 5.2 Americas In Vivo and In Vitro ADME and PK Market Size by Type (2016-2021)
  • 5.3 Americas In Vivo and In Vitro ADME and PK Market Size by End User (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC In Vivo and In Vitro ADME and PK Market Size by Region (2016-2021)
  • 6.2 APAC In Vivo and In Vitro ADME and PK Market Size by Type (2016-2021)
  • 6.3 APAC In Vivo and In Vitro ADME and PK Market Size by End User (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe In Vivo and In Vitro ADME and PK by Country (2016-2021)
  • 7.2 Europe In Vivo and In Vitro ADME and PK Market Size by Type (2016-2021)
  • 7.3 Europe In Vivo and In Vitro ADME and PK Market Size by End User (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa In Vivo and In Vitro ADME and PK by Region (2016-2021)
  • 8.2 Middle East & Africa In Vivo and In Vitro ADME and PK Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa In Vivo and In Vitro ADME and PK Market Size by End User (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global In Vivo and In Vitro ADME and PK Market Forecast

  • 10.1 Global In Vivo and In Vitro ADME and PK Forecast by Regions (2021-2026)
    • 10.1.1 Global In Vivo and In Vitro ADME and PK Forecast by Regions (2021-2026)
    • 10.1.2 Americas In Vivo and In Vitro ADME and PK Forecast
    • 10.1.3 APAC In Vivo and In Vitro ADME and PK Forecast
    • 10.1.4 Europe In Vivo and In Vitro ADME and PK Forecast
    • 10.1.5 Middle East & Africa In Vivo and In Vitro ADME and PK Forecast
  • 10.2 Americas In Vivo and In Vitro ADME and PK Forecast by Countries (2021-2026)
    • 10.2.1 United States In Vivo and In Vitro ADME and PK Market Forecast
    • 10.2.2 Canada In Vivo and In Vitro ADME and PK Market Forecast
    • 10.2.3 Mexico In Vivo and In Vitro ADME and PK Market Forecast
    • 10.2.4 Brazil In Vivo and In Vitro ADME and PK Market Forecast
  • 10.3 APAC In Vivo and In Vitro ADME and PK Forecast by Region (2021-2026)
    • 10.3.1 China In Vivo and In Vitro ADME and PK Market Forecast
    • 10.3.2 Japan In Vivo and In Vitro ADME and PK Market Forecast
    • 10.3.3 Korea In Vivo and In Vitro ADME and PK Market Forecast
    • 10.3.4 Southeast Asia In Vivo and In Vitro ADME and PK Market Forecast
    • 10.3.5 India In Vivo and In Vitro ADME and PK Market Forecast
    • 10.3.6 Australia In Vivo and In Vitro ADME and PK Market Forecast
  • 10.4 Europe In Vivo and In Vitro ADME and PK Forecast by Country (2021-2026)
    • 10.4.1 Germany In Vivo and In Vitro ADME and PK Market Forecast
    • 10.4.2 France In Vivo and In Vitro ADME and PK Market Forecast
    • 10.4.3 UK In Vivo and In Vitro ADME and PK Market Forecast
    • 10.4.4 Italy In Vivo and In Vitro ADME and PK Market Forecast
    • 10.4.5 Russia In Vivo and In Vitro ADME and PK Market Forecast
  • 10.5 Middle East & Africa In Vivo and In Vitro ADME and PK Forecast by Region (2021-2026)
    • 10.5.1 Egypt In Vivo and In Vitro ADME and PK Market Forecast
    • 10.5.2 South Africa In Vivo and In Vitro ADME and PK Market Forecast
    • 10.5.3 Israel In Vivo and In Vitro ADME and PK Market Forecast
    • 10.5.4 Turkey In Vivo and In Vitro ADME and PK Market Forecast
    • 10.5.5 GCC Countries In Vivo and In Vitro ADME and PK Market Forecast
  • 10.6 Global In Vivo and In Vitro ADME and PK Forecast by Type (2021-2026)
  • 10.7 Global In Vivo and In Vitro ADME and PK Forecast by End User (2021-2026)

11 Key Players Analysis

  • 11.1 Charles River
    • 11.1.1 Charles River Company Information
    • 11.1.2 Charles River In Vivo and In Vitro ADME and PK Product Offered
    • 11.1.3 Charles River In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Charles River Main Business Overview
    • 11.1.5 Charles River Latest Developments
  • 11.2 Labcorp
    • 11.2.1 Labcorp Company Information
    • 11.2.2 Labcorp In Vivo and In Vitro ADME and PK Product Offered
    • 11.2.3 Labcorp In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Labcorp Main Business Overview
    • 11.2.5 Labcorp Latest Developments
  • 11.3 ICON
    • 11.3.1 ICON Company Information
    • 11.3.2 ICON In Vivo and In Vitro ADME and PK Product Offered
    • 11.3.3 ICON In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 ICON Main Business Overview
    • 11.3.5 ICON Latest Developments
  • 11.4 Syneos Health
    • 11.4.1 Syneos Health Company Information
    • 11.4.2 Syneos Health In Vivo and In Vitro ADME and PK Product Offered
    • 11.4.3 Syneos Health In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Syneos Health Main Business Overview
    • 11.4.5 Syneos Health Latest Developments
  • 11.5 Envigo
    • 11.5.1 Envigo Company Information
    • 11.5.2 Envigo In Vivo and In Vitro ADME and PK Product Offered
    • 11.5.3 Envigo In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Envigo Main Business Overview
    • 11.5.5 Envigo Latest Developments
  • 11.6 Curia
    • 11.6.1 Curia Company Information
    • 11.6.2 Curia In Vivo and In Vitro ADME and PK Product Offered
    • 11.6.3 Curia In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Curia Main Business Overview
    • 11.6.5 Curia Latest Developments
  • 11.7 Evotec
    • 11.7.1 Evotec Company Information
    • 11.7.2 Evotec In Vivo and In Vitro ADME and PK Product Offered
    • 11.7.3 Evotec In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Evotec Main Business Overview
    • 11.7.5 Evotec Latest Developments
  • 11.8 Bioduro-Sundia
    • 11.8.1 Bioduro-Sundia Company Information
    • 11.8.2 Bioduro-Sundia In Vivo and In Vitro ADME and PK Product Offered
    • 11.8.3 Bioduro-Sundia In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Bioduro-Sundia Main Business Overview
    • 11.8.5 Bioduro-Sundia Latest Developments
  • 11.9 Lonza
    • 11.9.1 Lonza Company Information
    • 11.9.2 Lonza In Vivo and In Vitro ADME and PK Product Offered
    • 11.9.3 Lonza In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Lonza Main Business Overview
    • 11.9.5 Lonza Latest Developments
  • 11.10 WuXi AppTec
    • 11.10.1 WuXi AppTec Company Information
    • 11.10.2 WuXi AppTec In Vivo and In Vitro ADME and PK Product Offered
    • 11.10.3 WuXi AppTec In Vivo and In Vitro ADME and PK Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 WuXi AppTec Main Business Overview
    • 11.10.5 WuXi AppTec Latest Developments

11. IQVIA

  • 11.11.1 IQVIA Company Information
  • 11.11.2 IQVIA In Vivo and In Vitro ADME and PK Product Offered

According to this latest study, the 2021 growth of In Vivo and In Vitro ADME and PK will have significant change from previous year. By the most conservative estimates of global In Vivo and In Vitro ADME and PK market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the In Vivo and In Vitro ADME and PK market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of In Vivo and In Vitro ADME and PK market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Small Molecules
Biologics

Segmentation by end user: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Biopharmaceutical Companies
Government and Academic Institutes
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Charles River
Labcorp
ICON
Syneos Health
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences


Summary:
Get latest Market Research Reports on In Vivo and In Vitro ADME and PK. Industry analysis & Market Report on In Vivo and In Vitro ADME and PK is a syndicated market report, published as Global In Vivo and In Vitro ADME and PK Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of In Vivo and In Vitro ADME and PK market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,500.00
$7,000.00
2,621.50
5,243.00
3,094.00
6,188.00
398,650.00
797,300.00
263,025.00
526,050.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report